Advertisement

Topics

STAT Plus: Moderna leaves key questions unanswered as investors seek the reality behind the hype

17:24 EDT 14 Sep 2017 | STAT

Moderna's five-hour presentation to investors included cheery updates — but underlined lingering questions about whether it can live up to its own hype.

Original Article: STAT Plus: Moderna leaves key questions unanswered as investors seek the reality behind the hype

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: Moderna leaves key questions unanswered as investors seek the reality behind the hype"

Quick Search
Advertisement